Methicillin-resistant Staphylococcus aureusis a frequent pathogen in ABSSSIs. Ceftaroline fosamil is the first US FDA-approved cephalosporin with activity against Methicillin-resistant ...
The US FDA recently approved ceftaroline fosamil (ceftaroline) for the treatment of acute bacterial skin and soft structure infections (ABSSSIs) and community-acquired pneumonia. In 2010 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback